Fingerprint
Dive into the research topics of 'A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma
Ian D. Davis, Gregory A. Wiseman, Fook Thean Lee, Denise N. Gansen, Wendie Hopkins, Anthony T. Papenfuss, Zhanqi Liu, Timothy J. Moynihan, Gary A. Croghan, Alex A. Adjei, Eric W. Hoffman, James N. Ingle, Lloyd J. Old, Andrew M. Scott
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations